Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation
暂无分享,去创建一个
A. Talevi | G. Islan | G. R. Castro | I. León | M. L. Sbaraglini | V. Alvarez | C. Y. Chain | J. S. Cisneros | S. Scioli-Montoto | V. Ferretti | María Esperanza Ruiz | M. E. Ruiz | G. A. Islan
[1] F. Atyabi,et al. Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers , 2021, BioImpacts : BI.
[2] Gülşah Erel-Akbaba,et al. Development and Evaluation of Solid Witepsol Nanoparticles for Gene Delivery , 2021, Turkish journal of pharmaceutical sciences.
[3] Bhupinder Singh,et al. Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer's disease: A preclinical evidence. , 2021, Colloids and surfaces. B, Biointerfaces.
[4] A. Talevi,et al. Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices , 2021, Journal of Drug Delivery Science and Technology.
[5] L. Saini,et al. Efficacy and Safety of Phenobarbitone as First-Line Treatment for Neonatal Seizure: A Systematic Review and Meta-Analysis. , 2021, Journal of tropical pediatrics.
[6] Sebastián Scioli Montoto,et al. Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects , 2020, Frontiers in Molecular Biosciences.
[7] A. Holzer,et al. Selected Fatty Acids Esters as Potential PHB-V Bioplasticizers: Effect on Mechanical Properties of the Polymer , 2020, Journal of Polymers and the Environment.
[8] G. Islan,et al. Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing. , 2020, International journal of biological macromolecules.
[9] S. Allegretti,et al. Praziquantel-loaded solid lipid nanoparticles: Production, physicochemical characterization, release profile, cytotoxicity and in vitro activity against Schistosoma mansoni , 2020 .
[10] A. Zeb,et al. Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. , 2020, Colloids and surfaces. B, Biointerfaces.
[11] J. Moreira,et al. Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review. , 2020, Nanomedicine : nanotechnology, biology, and medicine.
[12] N. Ahmad,et al. Quantification and Evaluations of Catechin Hydrate Polymeric Nanoparticles Used in Brain Targeting for the Treatment of Epilepsy , 2020, Pharmaceutics.
[13] G. R. Castro,et al. Lipid nanoparticles – Metvan: revealing a novel way to deliver a vanadium compound to bone cancer cells , 2019, New Journal of Chemistry.
[14] Robert J. Lee,et al. Solid lipid nanoparticles as a drug delivery system to across the blood-brain barrier. , 2019, Biochemical and biophysical research communications.
[15] A. Talevi,et al. Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties. , 2019, International journal of pharmaceutics.
[16] Nicolas James Ho,et al. Piperine-loaded nanoparticles with enhanced dissolution and oral bioavailability for epilepsy control. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] Fares Alahdab,et al. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.
[18] Mitali H Patel,et al. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies , 2019, Artificial cells, nanomedicine, and biotechnology.
[19] A. Talevi,et al. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation. , 2018, Colloids and surfaces. B, Biointerfaces.
[20] Smriti Ojha. In vitro and In vivo neuroprotective study of solid lipid nanoparticles loaded with dimethyl fumarate , 2018 .
[21] L. Gadaga,et al. Intestinal Permeability of Artesunate-Loaded Solid Lipid Nanoparticles Using the Everted Gut Method , 2018, Journal of drug delivery.
[22] N. Williams,et al. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells , 2018, Scientific Reports.
[23] T. Borg,et al. Topical phenytoin nanostructured lipid carriers: design and development , 2018, Drug development and industrial pharmacy.
[24] Björn Bauer,et al. Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers , 2017, Front. Neurol..
[25] R. Saha,et al. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[26] J. Kehne,et al. The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP) , 2017, Neurochemical Research.
[27] C. Ghelardini,et al. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. , 2017, International journal of pharmaceutics.
[28] J. Kohlbrecher,et al. Rapamycin-loaded solid lipid nanoparticles: Morphology and impact of the drug loading on the phase transition between lipid polymorphs , 2016 .
[29] Hui Li,et al. Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity , 2016, International journal of nanomedicine.
[30] N. Durán,et al. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization. , 2016, Colloids and surfaces. B, Biointerfaces.
[31] Christel A. S. Bergström,et al. 50years of oral lipid-based formulations: Provenance, progress and future perspectives. , 2016, Advanced drug delivery reviews.
[32] P. Pasinelli,et al. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders , 2015, Brain Research.
[33] F. Cendes,et al. The consequences of refractory epilepsy and its treatment , 2014, Epilepsy & Behavior.
[34] B. D. Anderson,et al. Dynamic, Nonsink Method for the Simultaneous Determination of Drug Permeability and Binding Coefficients in Liposomes , 2014, Molecular pharmaceutics.
[35] Ulrike Grömping,et al. R Package FrF2 for Creating and Analyzing Fractional Factorial 2-Level Designs , 2014 .
[36] Rainer H Müller,et al. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[37] M. Brandl,et al. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. , 2012, International journal of pharmaceutics.
[38] H. Potschka. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport. , 2012, Advanced drug delivery reviews.
[39] E. Aronica,et al. Cerebral expression of drug transporters in epilepsy. , 2012, Advanced drug delivery reviews.
[40] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[41] Ashok Kumar,et al. Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine , 2012, Lipids in Health and Disease.
[42] D. Apperley,et al. Structural Features, Phase Relationships and Transformation Behavior of the Polymorphs I−VI of Phenobarbital , 2010 .
[43] Russell V. Lenth,et al. Response-Surface Methods in R, Using rsm , 2009 .
[44] Wolfgang Löscher,et al. Several major antiepileptic drugs are substrates for human P-glycoprotein , 2008, Neuropharmacology.
[45] J. Vilela,et al. Atomic Force Microscopy Applied to the Characterization of Solid Lipid Nanoparticles , 2005, Microscopy and Microanalysis.
[46] M. Fathy,et al. PREPARATION AND EVALUATION OF PIROXICAM - PLURONIC SOLID DISPERSIONS , 2003 .
[47] H. Fessi,et al. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[48] K. Mäder,et al. Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.
[49] A. Thünemann,et al. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. , 2000, International journal of pharmaceutics.
[50] G. V. Aken,et al. Polymorphism of milk fat studied by differential scanning calorimetry and real-time X-ray powder diffraction , 1999 .
[51] R. Müller,et al. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[52] K. L. Smith. Controlled release of biologically active agents , 1989 .
[53] Nicholas A. Peppas,et al. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .
[54] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[55] L. S. Nelson,et al. The Nelder-Mead Simplex Procedure for Function Minimization , 1975 .
[56] J. Westwater,et al. The Mathematics of Diffusion. , 1957 .
[57] D. Andersson,et al. Efficacy and safety , 2018 .
[58] A. Bilia,et al. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. , 2018, Colloids and surfaces. B, Biointerfaces.
[59] Jerry Nesamony,et al. Solid Lipid Nanoparticles in Drug Delivery , 2017 .
[60] A. Talevi,et al. Discovering New Antiepileptic Drugs Addressing the Transporter Hypothesis of Refractory Epilepsy: Ligand-Based Approximations , 2016 .
[61] Christopher J. H. Porter,et al. years of oral lipid-based formulations : Provenance , progress and future perspectives ☆ , 2016 .
[62] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[63] Manini Patel,et al. Solid Lipid Nanoparticles , 2014 .
[64] N. Fotaki,et al. Investigation on the Use of Dialysis Membrane on Drug Release from Micro Particles in Compendial Apparatus 1 and 3 , 2014 .
[65] Guideline on quality of oral modified release products 4 Draft 5 , 2012 .
[66] S. Verma,et al. ROUTES OF DRUG ADMINISTRATION , 2010 .
[67] W. G. D. Ruig. Infrared spectra of monoacid triglycerides: With some applications to fat analysis , 1971 .
[68] A. Hauptmann. Luminal bei Epilepsie , 1912 .